Companies: 10,795·Total market cap: $144.5T
Pharmadrug Inc.

Pharmadrug Inc.

LMLLFOTCHealthcare● Active
$0.01
$-0.00(-20.45%)
Market Cap$757638
P/E Ratio
52W High$0.0173
52W Low$0.0022
Overview

Pharmadrug Inc. (LMLLF) Revenue

Annual & quarterly revenue history · segment & region breakdown

LMLLF · revenue · updated Jun 9, 2026

Core revenue metrics

Pharmadrug Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
9 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Pharmadrug Inc. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
LMLLF revenue by year · LMLLF revenue history · LMLLF annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Pharmadrug Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Pharmadrug Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Pharmadrug Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

LMLLF revenue · 4 questions

LMLLF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

LMLLF revenueLMLLF annual revenuewhat is LMLLF revenueLMLLF TTM revenue

Source: FMP · Pharmadrug Inc. SEC filings · GAAP · Pharmadrug Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026